Regular articleTumorigenesis and neoplastic progressionCaveolin-1 and Accelerated Host Aging in the Breast Tumor Microenvironment: Chemoprevention with Rapamycin, an mTOR Inhibitor and Anti-Aging Drug
Cited by (0)
Supported by grants from the NIH/National Cancer Institute (R01-CA-80250, R01-CA-098779, and R01-CA-120876 to M.P.L.), the American Association for Cancer Research (M.P.L), the Department of Defense–Breast Cancer Research Program (Synergistic Idea Award) (M.P.L.), a grant from the Pennsylvania Department of Health (M.P.L.), a postdoctoral fellowship from the Susan G. Komen Breast Cancer Foundation (I.M.), and a career catalyst award from the Susan G. Komen Breast Cancer Foundation (J.-F.J.).
The Pennsylvania Department of Health disclaims responsibility for any analyses, interpretations, or conclusions.
A guest editor acted as editor-in-chief for this manuscript. No person at Thomas Jefferson University or Albert Einstein College of Medicine was involved in the peer review process or final disposition for this article.